SOFIE
PrivateLast Round
Private Equity
Jun 4, 2024
Est. Valuation
$540.43M
Total Funding Raised
$53.15M
Company Overview
SOFIE is a healthcare technology company that develops molecular imaging probes and devices to provide radiopharmaceutical products for in vivo research, assisting physicians in identifying tumors responsive to targeted therapies and enhancing personalized healthcare through innovative theranostics.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Imaging, Clinical Trials, Pharma Supply Chain, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
SOFIE Comparables
Compare SOFIE with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| PharmaLogic Holdings Corp. | 87% | |
| PharmaLogic Holdings Corp. | 84% | |
| SpectronRx | 83% | |
SOFIE Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Private Equity | Jun 4, 2024 | ||||
| Series C | Nov 4, 2020 | ||||
| Convertible Debt | Jul 12, 2019 | ||||
| Grant | Oct 5, 2018 | ||||
| Series B | Apr 12, 2018 | ||||
VC Round | Jun 13, 2016 |
Key People
Founding team and executive leadership
SOFIE Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Institute of Biomedical Imaging and Bioengineering | Grant |
| National Cancer Institute | Grant |
| Trilantic North America | Private Equity |
| Cycad Group | Seed, Grant |
| Tata Industries Limited | Grant |
| MRM Capital Holdings | Grant |
| National Institute of Mental Health | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 2, 2026
Developing new radiopharmaceutical FAPI-74 for theranostic use.
- Oct 5, 2018
$5M grant from National Cancer Institute and others.
SOFIE Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about SOFIE's valuation, stock price, and market status.